Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps

Status Terminated

Clinical Trial Summary

The purpose of this randomized controlled double-blinded trial is to determine if the addition of an oral antifungal to typical post-operative medical therapy can prevent or reduce the incidence of recurrence of nasal polyps in fungal sensitive patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Clinical Trial Description

CRSwNP patients scheduled for medically-indicated sinus surgery will undergo screening ELIspot assay to identify patients with fungal sensitivity based on positive fungal induced interleukin 4 (IL-4) ELIspot. Enrolled fungal sensitive CRSwNP patients will undergo their sinus surgery and randomized into either placebo or itraconazole 200 mg taken by mouth twice a day (PO BID) for 24 weeks in addition to standardized post-surgical regimen (9 days of perioperative prednisone, saline irrigations and pain medication as needed). Patients will be followed as outpatient in rhinology clinic for 48 weeks total. During these post-op visits, compliance with medications will be determined. Patients will be questioned about any possible side effects or adverse events to post-operative medications. Then, the patients will be evaluated by 2 nasal specific quality of life questionnaires and nasal endoscopy. The goals of the nasal endoscopy are to evaluate the state of the sinus mucosa and to determine recurrence of nasal polyps. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02285283
Study type	Interventional
Source	The University of Texas Health Science Center, Houston
Contact
Status	Terminated
Phase	Phase 2/Phase 3
Start date	November 2014
Completion date	May 15, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04131686` - NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis
Completed	`NCT02692794` - Large Scale Cerebral Oximetry During Sinus Endoscopy	N/A
Completed	`NCT01988779` - Oral Versus Topical Antibiotics for Chronic Rhinosinusitis Exacerbations	Phase 3
Completed	`NCT01254916` - The Sinonasal Outcome Test - 22, Validated for Danish Patients	N/A
Completed	`NCT03614923` - Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)	Phase 2
Completed	`NCT03781804` - Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps	Phase 3
Completed	`NCT01198912` - Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial	Phase 2
Active, not recruiting	`NCT06457100` - Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery	Phase 1/Phase 2
Completed	`NCT03280537` - A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps	Phase 3
Completed	`NCT02307825` - Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy	Phase 4
Completed	`NCT02218307` - The Use of Antibiotic Sinonasal Rinse After Sinus Surgery	Phase 4
Recruiting	`NCT01024075` - Effect of Sinufoam-Dexamethasone Mixture on Post Endoscopic Sinus Surgery Outcomes	Phase 4
Completed	`NCT01002313` - Effect of Prednisone onTregs and TH17	Phase 1
Completed	`NCT00396162` - Use of Probiotics as Adjunctive Treatment for Chronic Rhinosinusitis	Phase 4
Completed	`NCT03280550` - A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps	Phase 3
Recruiting	`NCT05935683` - Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis
Completed	`NCT03478930` - An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps	Phase 3
Completed	`NCT01943370` - Early Saline Irrigation to Decrease Post-operative Endoscopic Debridement	N/A
Completed	`NCT02154555` - A Randomized Controlled Trial Evaluating Postoperative Debridement Following Endoscopic Sinus Surgery	N/A
Completed	`NCT01778465` - Effect of Dietary Salicylate in Aspirin Exacerbated Respiratory Disease	N/A